相关实验视频
Updated: Jan 11, 2026

09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
30.2K
综合性基因组分析揭示了乳腺乳腺组织基因表达和乳腺癌风险之间的因果关系,使用多方法的门德尔随机化
1Department of Oncology, Nantong No. 1 People's Hospital, Nantong City, 226000, Jiangsu Province, China. xianyou2025@126.com.
Discover oncology
|November 19, 2025
概括
这项研究揭示了乳腺组织中的关键基因,其表达影响乳腺癌风险. 识别这些遗传联系有助于开发乳腺癌的新预防和治疗策略.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 遗传流行病学遗传流行病学
背景情况:
- 了解乳腺组织中的基因表达对于预防和治疗乳腺癌至关重要.
- 观察性研究面临诸如混因素和反向因果关系等局限性.
研究的目的:
- 研究乳腺乳腺组织基因表达与乳腺癌风险之间的因果关系.
- 确定特定的基因及其在乳腺癌易感性中的作用.
主要方法:
- 采用多分析方法:孟德尔随机化 (MR),基于摘要的孟德尔随机化 (SMR) 和全转录组关联研究 (TWAS).
- 利用了大规模的全基因组关联研究 (GWAS) 总结统计和表达量化特征位置 (eQTL) 数据.
主要成果:
- 在MR中,APOBEC3B,SLC22A5和CRLF3被确定为保护基因.
- TWAS强调SLC4A7和NEGR1是与风险相关的,而ZBTB38,RGPD1,CCDC91是保护性的.
- SMR分析证实了相关性,并确定了额外的风险和保护基因.
结论:
- 这种综合性基因组分析证实了乳腺组织中的特定基因表达模式与乳腺癌风险之间的因果关系.
- 这些发现为新的治疗目标和预防策略提供了基础.
关键词:
APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B APOBEC3B乳腺癌 乳腺癌 乳腺癌因果推断的原因推断是因果推断.基因表达 基因表达 基因表达乳腺组织 乳腺组织门德尔的随机化在NEGR1中,它是黑色的.在 SLC4A7A7 中.这是一个SMR,SMR是SMR.在TWAS中,TWAS就是TWAS.更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.4K
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.6K
相关概念视频
Epistasis Analysis
5.6K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.6K
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K